These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 20435730)

  • 41. Stationary phase persister formation in Escherichia coli can be suppressed by piperacillin and PBP3 inhibition.
    Aedo SJ; Orman MA; Brynildsen MP
    BMC Microbiol; 2019 Jun; 19(1):140. PubMed ID: 31234796
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Survival of bactericidal antibiotic treatment by tolerant persister cells of Klebsiella pneumoniae.
    Li Y; Zhang L; Zhou Y; Zhang Z; Zhang X
    J Med Microbiol; 2018 Mar; 67(3):273-281. PubMed ID: 29458540
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Genetic Determinant of Persister Cell Formation in Bacterial Pathogens.
    Cameron DR; Shan Y; Zalis EA; Isabella V; Lewis K
    J Bacteriol; 2018 Sep; 200(17):. PubMed ID: 29941425
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resuscitation dynamics reveal persister partitioning after antibiotic treatment.
    Fang X; Allison KR
    Mol Syst Biol; 2023 Apr; 19(4):e11320. PubMed ID: 36866643
    [TBL] [Abstract][Full Text] [Related]  

  • 45. (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one sensitizes Escherichia coli persister cells to antibiotics.
    Pan J; Xie X; Tian W; Bahar AA; Lin N; Song F; An J; Ren D
    Appl Microbiol Biotechnol; 2013 Oct; 97(20):9145-54. PubMed ID: 24006079
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proteomic Investigation of Tolerant
    Sulaiman JE; Lam H
    J Proteome Res; 2020 Feb; 19(2):900-913. PubMed ID: 31920087
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Persister cells and tolerance to antimicrobials.
    Keren I; Kaldalu N; Spoering A; Wang Y; Lewis K
    FEMS Microbiol Lett; 2004 Jan; 230(1):13-8. PubMed ID: 14734160
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proteomic Study of the Survival and Resuscitation Mechanisms of Filamentous Persisters in an Evolved Escherichia coli Population from Cyclic Ampicillin Treatment.
    Sulaiman JE; Lam H
    mSystems; 2020 Jul; 5(4):. PubMed ID: 32723793
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Persister eradication: lessons from the world of natural products.
    Keren I; Mulcahy LR; Lewis K
    Methods Enzymol; 2012; 517():387-406. PubMed ID: 23084949
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bacterial persistence as a phenotypic switch.
    Balaban NQ; Merrin J; Chait R; Kowalik L; Leibler S
    Science; 2004 Sep; 305(5690):1622-5. PubMed ID: 15308767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Medium chain unsaturated fatty acid ethyl esters inhibit persister formation of Escherichia coli via antitoxin HipB.
    Wang M; Fang K; Hong SMC; Kim I; Jang IS; Hong SH
    Appl Microbiol Biotechnol; 2018 Oct; 102(19):8511-8524. PubMed ID: 30088019
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Persister Heterogeneity Arising from a Single Metabolic Stress.
    Amato SM; Brynildsen MP
    Curr Biol; 2015 Aug; 25(16):2090-8. PubMed ID: 26255847
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The formation of persister cells in stationary-phase cultures of Escherichia coli is associated with the aggregation of endogenous proteins.
    Leszczynska D; Matuszewska E; Kuczynska-Wisnik D; Furmanek-Blaszk B; Laskowska E
    PLoS One; 2013; 8(1):e54737. PubMed ID: 23358116
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibiotic induced bacterial lysis provides a reservoir of persisters.
    Podlesek Z; Butala M; Šakanović A; Žgur-Bertok D
    Antonie Van Leeuwenhoek; 2016 Apr; 109(4):523-8. PubMed ID: 26821377
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The fatty acid signaling molecule cis-2-decenoic acid increases metabolic activity and reverts persister cells to an antimicrobial-susceptible state.
    Marques CN; Morozov A; Planzos P; Zelaya HM
    Appl Environ Microbiol; 2014 Nov; 80(22):6976-91. PubMed ID: 25192989
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Persister formation in Escherichia coli can be inhibited by treatment with nitric oxide.
    Orman MA; Brynildsen MP
    Free Radic Biol Med; 2016 Apr; 93():145-54. PubMed ID: 26849946
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bacterial persisters tolerate antibiotics by not producing hydroxyl radicals.
    Kim JS; Heo P; Yang TJ; Lee KS; Jin YS; Kim SK; Shin D; Kweon DH
    Biochem Biophys Res Commun; 2011 Sep; 413(1):105-10. PubMed ID: 21872573
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ploidy is an important determinant of fluoroquinolone persister survival.
    Murawski AM; Brynildsen MP
    Curr Biol; 2021 May; 31(10):2039-2050.e7. PubMed ID: 33711253
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Single-cell protein induction dynamics reveals a period of vulnerability to antibiotics in persister bacteria.
    Gefen O; Gabay C; Mumcuoglu M; Engel G; Balaban NQ
    Proc Natl Acad Sci U S A; 2008 Apr; 105(16):6145-9. PubMed ID: 18427112
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phenotypic heterogeneity enables uropathogenic Escherichia coli to evade killing by antibiotics and serum complement.
    Putrinš M; Kogermann K; Lukk E; Lippus M; Varik V; Tenson T
    Infect Immun; 2015 Mar; 83(3):1056-67. PubMed ID: 25561706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.